Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AgenDx Biosciences logo — company profile

AgenDx Biosciences

Founded 2014 Seed Total: $1.53M Health Care

General Information

Company Name AgenDx Biosciences
Founded Year 2014
Industries Health Care
Funding Stage Seed
Social

Get notified when AgenDx Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AgenDx Biosciences

AgenDx Biosciences is an early stage molecular diagnostics company founded in 2014, with a recent $675.00KSeed Round investment at 07 February 2018 from IrishAngels, Elevate Ventures, University of Notre Dame, and The Judd Leighton Foundation. The company is dedicated to developing a cost-effective platform for molecular diagnostics, featuring technology that enables simple, lab-quality testing with rapid sample-to-answer time in minutes. AgenDx's platform supports a wide variety of nucleic-acid based tests for infectious diseases, cancer, and chronic conditions such as cardiovascular disease and arthritis. The company is initially focusing on proving the AgenDx technology by developing tests for pancreatic cancer treatment decision support. The platform is designed for use by untrained individuals in clinical settings near the patient, allowing for the collection of samples such as blood, saliva, and tissues and the automation of testing processes with clear result display and transmission.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 4
Investor Investor Investor Investor
07 Feb 2018
Seed Round •••••• 1
Investor
19 Jan 2016
Angel Round •••••• 1
Investor
14 Dec 2014

AgenDx Biosciences Alternatives & Competitors

AgenDx Biosciences vs
BioGX
BioGX United States

MOLECULAR MADE EASY

60 employees
Biotechnology, Manufacturing
AgenDx Biosciences vs
Arquer Diagnostics
Arquer Diagnostics United Kingdom

Leading the way in non-invasive tests for diagnosing and monitoring cancer.

Convertible Note
3 employees
Biotechnology, Health Care
AgenDx Biosciences vs
Wren Laboratories
Wren Laboratories United States

Unleashing the Power of mRNA and AI for Cancer Diagnostics

25 employees
Biotechnology, Health Care

FAQ About AgenDx Biosciences

AgenDx is an early stage molecular diagnostics company developing a cost-effective platform for molecular diagnostics. Their unique technology provides simple, lab-quality testing for molecular diagnostics. With a rapid sample-to-answer time in minutes, their platform is set to change where and how...
AgenDx Biosciences was founded in 2014.
AgenDx Biosciences operates in the following industries: Health Care.
AgenDx Biosciences has completed 3 funding rounds, raising a total of $1.53M. The latest funding stage is Seed.
Top alternatives and competitors to AgenDx Biosciences include BioGX, Arquer Diagnostics, Wren Laboratories, Xagenic, Monogram Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AgenDx Biosciences and BioGX are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AgenDx Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy